Back to Search
Start Over
Quality and Efficacy Concerns with Generics in Treatment of Hepatitis C with Directly Acting Antivirals
- Source :
- Journal of the Dow University of Health Sciences, Vol 11, Iss 2, Pp 29-30 (2017)
- Publication Year :
- 2017
- Publisher :
- Dow University of Health Sciences, 2017.
-
Abstract
- Treating hepatitis C has never been so convenient after the advent of Directly Acting Antivirals (DAA). Convenience is at both ends; for the doctors to prescribe and for patients to comply due to all oral therapy with few adverse effects. Many are already in market, these include, Sofosbuvir, Declastavir & Velpastavir while many others are in pipeline.
- Subjects :
- Medicine
Subjects
Details
- Language :
- English
- ISSN :
- 19952198 and 24102180
- Volume :
- 11
- Issue :
- 2
- Database :
- Directory of Open Access Journals
- Journal :
- Journal of the Dow University of Health Sciences
- Publication Type :
- Academic Journal
- Accession number :
- edsdoj.7298ed2900f34b0eba7e6b6a72de1d99
- Document Type :
- article
- Full Text :
- https://doi.org/10.36570/jduhs.2017.2.001